# A Rugged, Reliable, Portable, Safe, and Simple Naloxone HCl Auto-Injector forLife-Saving Treatment of Opioid Overdose

> **NIH NIH R43** · PIROUETTE MEDICAL · 2024 · $55,000

## Abstract

Project Abstract
136 people die each day from opioid overdose in the US. Naloxone has significantly decreased
opioid mortality as a first line life-saving measure, and often it is being administered by
untrained medical personnel under situations of extreme stress—which studies show leads to
accidents, missed doses and tragic consequences. Pirouette has designed a novel, low-cost,
and intuitive auto-injector called REZQGO that anyone could use to deliver lifesaving Naloxone
safely and quickly during an opioid overdose; this Phase I project supplement will assist
Pirouette in market research, regulatory planning, pricing / reimbursement strategy, usability,
and the commercialization / GMP implementation of the REZQGO product lineup.
Pirouete Medical Inc. Conﬁden�al

## Key facts

- **NIH application ID:** 10987197
- **Project number:** 3R43DA059474-01S1
- **Recipient organization:** PIROUETTE MEDICAL
- **Principal Investigator:** Conor R Cullinane
- **Activity code:** R43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $55,000
- **Award type:** 3
- **Project period:** 2024-02-01 → 2024-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10987197

## Citation

> US National Institutes of Health, RePORTER application 10987197, A Rugged, Reliable, Portable, Safe, and Simple Naloxone HCl Auto-Injector forLife-Saving Treatment of Opioid Overdose (3R43DA059474-01S1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10987197. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*